Oncotarget: Predicting clinical outcomes using cancer progression associated signatures
The P142 panel of metrics successfully predicted cancer progression status in patients with some, but not all cancer types analyzed. ...
The P142 panel of metrics successfully predicted cancer progression status in patients with some, but not all cancer types analyzed. ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.